Temple Times Online Edition
    September 28, 2006
NewsEventsArchivesPhotosStaffLinksTemple Home

Temple Lung Center receives top honors


The Temple Lung Center recently received two honors for its leadership in respiratory disease diagnosis, treatment and research, as well as for high safety standards and quality of care.


Best Hospitals logo

The first honor came from U.S. News & World Report, which ranked Temple University Hospital as one of the nation’s top hospitals for respiratory disorders in their 2006 “Best Hospitals” survey.  Temple was one of only two Philadelphia-based hospitals to earn national honors for its respiratory disorders program.  


Additionally, the Joint Commission on the Accreditation of Healthcare Organizations granted national certification to Temple as a Center for Lung Volume Reduction Surgery (LVRS), a treatment for emphysema. Temple is the first hospital in Philadelphia, and among the first academic hospitals in the nation, to receive the Joint Commission’s Gold Seal of Approval for LVRS.


The Temple Lung Center was the East Coast’s top recruiter for the National Emphysema Treatment Trial that studied LVRS, is an active clinical site for the National, Heart, Lung and Blood Institute’s COPD Clinical Research Network and the lead institution on the Pennsylvania Study of COPD Exacerbations.


Pulmonary team outside Temple Hospital
The Temple Lung Center’s multidisciplinary, team-oriented approach (as many as 200 clinicians and administrators contribute to care) pays off with excellent clinical outcomes and national recognition. (Photo by Joseph V. Labolito / University Photography)

Joint Commission certification means a program complies with the highest national standards for safety and quality of care. To earn this distinction, Temple’s LVRS program underwent an extensive review of patient cases; compliance with professional standards; an assessment of caregivers’ qualifications; and interviews with staff, patients and families.


“Temple’s Lung Center continues to pioneer and provide the most advanced treatments to patients with the most challenging respiratory disorders and pulmonary diseases, such as pulmonary fibrosis, hypertension, respiratory failure, chronic obstructive pulmonary disease and mechanical ventilation,” said Gerard J. Criner, professor of medicine at the School of Medicine, and director of pulmonology and critical care medicine at the Hospital.          

Eryn Jelesiewicz





Since 1970, the Temple Times has been Temple's weekly newspaper for the University community. Learn more about the Temple Times.